Birchview Capital »

Bioage Labs shares owned by Birchview Capital

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Birchview Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 69k 24.51

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Lam Research Corporation Com New (LRCX)
Solid Biosciences Com New (SLDB)
Intellia Therapeutics (NTLA)
Biodesix
Stoke Therapeutics (STOK)
Encana Corporation (OVV)
Nektar Therapeutics (NKTR)
Corcept Therapeutics Incorporated (CORT)
Neurocrine Biosciences (NBIX)
Prothena Corp SHS (PRTA)
ACADIA Pharmaceuticals (ACAD)
Protagonist Therapeutics (PTGX)
Compass Therapeutics (CMPX)

View all positions for Birchview Capital

Top funds holding Bioage Labs

AH Capital Management
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Jupiter Topco
Henderson Group
Octagon Capital Advisors
RA Capital Management
MPM Oncology Impact Management
Vanguard Capital Management
Polar Capital Holdings
Braidwell
Geode Capital Management
State Street Corporation
Sands Capital Ventures

View all funds holding Bioage Labs